These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Rohypnol ("roofies") control of drug discrimination: effect of coadministered ethanol or flumenazil.
    Author: Schechter MD.
    Journal: Pharmacol Biochem Behav; 1998 Jan; 59(1):19-25. PubMed ID: 9443531.
    Abstract:
    The benzodiazepine flunitrazepam (Rohypnol) was employed to control differentially discriminative performance in 10 Sprague-Dawley rats on a food-motivated FR10 schedule. The training dose was 2.5 mg/kg, and 20 min was employed between intraperitoneal administration and training; both values were employed in this study, which, in reality, is the first time in the drug discrimination literature for the training of this drug. Dose-response experiments indicated decreasing discriminative performance in concert with decreasing time to reach FR10 lever selection as the dose tested decreased from 2.5 to 0.04 mg/kg. The calculated ED50 for discriminative performance, i.e., lever selection of the drug-correct lever, was 0.076 mg/kg. The relatively few sessions needed to reach discrimination criterion, and the fact that the ED50 value was 1/33 of the training dose, suggests that a lower dose of Rohypnol may be used in the future to train rats in this paradigm. Time course experiments indicate decreasing discriminative performance from 20-240 min postadministration with a calculated half-life of 162.3 min. Administration of 450, 600, and 900 mg/kg ethanol (10% w/v) I.P. produced saline-like discriminative responding, whereas the combination of these doses with the 0.08 mg/kg Rohypnol dose produced increasing discriminative performance with the highest ethanol dose producing 72.2% Rohypnol-appropriate lever selections in a mean time to attain lever selection on the FR10 schedule of 12.8 s. These results suggest that a lower training dose of Rohypnol may allow for testing of a smaller ED50 Rohypnol dose with ethanol to produce a more complete generalization. The ability of flumenazil (Ro 15-1788) to dose dependently block the discrimination of Rohypnol suggests that this benzodiazepine produces its action by its agonistic efficacy at these receptors. The coadministration of Rohypnol and ethanol as a popular drug combination in humans is discussed, and evidence is offered as to their synergistic interactions in rat discrimination.
    [Abstract] [Full Text] [Related] [New Search]